Sinopharm unit`s vaccine safe for those aged 3-17: China media
(WorldNews Asia)

BEIJING • A Covid-19 vaccine developed by China National Biotec Group (CNBG), a unit of Sinopharm, is safe in those aged between three and 17, based on clinical data obtained by the company, state media reported. `It should be noted that for three-to five-year-old children,...